Futura Medical plc (AIM: FUM)
37.00
-1.00 (-2.63%)
Sep 11, 2024, 4:36 PM GMT+1
Futura Medical Company Description
Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health.
Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Futura Medical plc
Country | United Kingdom |
Founded | 2001 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 12 |
CEO | James Barder |
Contact Details
Address: Surrey Technology Centre Guildford, GU2 7YG United Kingdom | |
Phone | 44 14 8368 5670 |
Website | futuramedical.com |
Stock Details
Ticker Symbol | FUM |
Exchange | London Stock Exchange AIM |
Fiscal Year | January - December |
Reporting Currency | GBP |
ISIN Number | GB0033278473 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
James Barder | Chief Executive Officer |
Angela Hildreth | Chief Financial Officer |
Angela Hildreth | Chief Operating Officer |